Literature DB >> 18390140

Socio demographic profile and presentations of patients with ruptured gravid uterus in Calabar Nigeria.

E I Ekanem1, S J Etuk, M I Ekott, J E Ekabua, C Iklaki.   

Abstract

BACKGROUND: To study the Socio-demographic profiles and mode of clinical presentations of with uterine rupture in pregnancy in Calabar, Nigeria.
METHOD: Medical records of 67 patients managed for ruptured gravid uterus over 10 years in Maternity section of the University of Calabar Teaching Hospital Calabar, Nigeria were reviewed.
RESULTS: An incidence of 1 in 213 of all deliveries during the period was established. Majority (49.2%) were aged between 31 to 40 years and 43.3% had no formal education. Unemployed patients were 29.9%, 42.3% did not book for antenatal care while 32.8% were attended to by traditional birth attendants (TBA) and in the churches. The Commonest clinical presentations were fetal heart rate abnormalities (52.2%) and maternal collapse (46.3%). Majority (50.7%) resulted from neglected obstructed labour.
CONCLUSION: Ruptured uterus is a problem of ignorance among women of low socioeconomic group with most of them having unskilled and substandard care during pregnancy and delivery. Improvement in Socio-economic conditions and modification of some harmful cultural practices against women generally will reduce the problem of rupture uterus in our society.

Entities:  

Mesh:

Year:  2008        PMID: 18390140     DOI: 10.4314/njm.v17i1.37362

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  2 in total

1.  Uterine rupture in a teaching hospital in Mbarara, western Uganda, unmatched case- control study.

Authors:  Peter K Mukasa; Jerome Kabakyenga; Jude K Senkungu; Joseph Ngonzi; Monica Kyalimpa; Van J Roosmalen
Journal:  Reprod Health       Date:  2013-05-29       Impact factor: 3.223

2.  When women deliver with no one present in Nigeria: who, what, where and so what?

Authors:  Bolaji M Fapohunda; Nosakhare G Orobaton
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.